Greater China
SIG leads $100m round for China gaming platform MetaApp
China gaming platform MetaApp has raised a $100 million Series C round led by SIG and featuring existing investors China Creation Ventures (CCV) and Sky9 Capital. It is said to be the largest single round in China's gaming industry.
China e-signature specialist Fadada gets $139m Series D
Tencent Holdings, Centurium Capital, and ZWC Partners have contributed RMB900 million ($139 million) in Series D funding to Fadada, a Chinese e-signature and cloud contract service provider.
GL joins $61m Series C for China's Thousand Oaks
GL Ventures - a VC unit of Hillhouse Capital - and China State-Owned Capital Venture Investment Fund have led a RMB400 million ($61 million) Series C round for Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization...
China regulation: Taming the giants
Recent regulatory reforms suggest that China will not let the growth of large technology companies go unchecked. The implications could be far-reaching, not least for VC investors and start-ups
Loyal Valley leads Series B for China vision therapy start-up
China-based eye disorder specialist Arctic Vision has raised a $100 million Series B round led by Loyal Valley Capital. Tencent Holdings, Octagon Capital, and New World Development CEO Adrian Cheng also participated.
China's Zhongneng secures $460m in equity, debt funding
Zhongneng United, a Chinese construction equipment rental platform specializing in aerial work, has raised RMB3 billion ($460 million) in Series C equity and debt financing across three tranches.
Allianz leads $75m round for Hong Kong's WeLab
Allianz Group has led a $75 million round for Hong Kong’s WeLab with a view to helping the financial technology provider develop new insurance and investment products.
FountainVest leads $100m round for China's Ushopal
FountainVest Partners has led a $100 million funding round for Ushopal, a China-focused e-commerce platform that sources global luxury brands for the high-end consumer market.
China LiDAR specialist Innovusion raises $60m
Innovusion, a Chinese developer of LiDAR technology used in autonomous driving, has raised $60 million in funding. The company is best known as a supplier to domestic electric vehicle (EV) manufacturer Nio.
Addor raises $241m for second China healthcare fund
Addor Capital – a Chinese VC firm backed by Jiangsu High-Tech Investment Group, also known as Govtor Capital – has raised RMB1.56 billion ($241 million) for its second renminbi-denominated healthcare fund.
Founder of China's Zhencheng Capital launches SPAC
Jianwei Li, founding and managing partner of Chinese venture capital firm Zhencheng Capital and previously CIO at ZhenFund, has launched a special purpose acquisition company (SPAC).
PE-backed SciClone achieves $1.6b market cap on HK re-listing
SciClone Pharmaceuticals, a Chinese drug developer privatized by a PE consortium at a valuation of $605 million in 2017, has relisted in Hong Kong and ended its first day of trading with a market capitalization of HK$12.7 billion ($1.64 billion).
Chinese GPU chip designer raises $186m
Iluvatar CoreX, a Shanghai-based computing chip designer has raised RMB1.2 billion ($186 million) in Series C funding led by Cedarlake Capital and Centurium Capital.
Deal focus: ANE Logistics targets attractive middle
China’s less-than-truckload logistics market, which sits in between express couriers and big truck operators, is ripe for consolidation. GPs have identified their favored players
Affinity adds to China team
Affinity Equity Partners has recruited Sam Sun, previously a partner at Sequoia Capital, as a managing director based in Beijing.
GPs & SPACs: Filthy lucre?
The global SPAC craze is percolating into Asia, with private equity firms among the sponsors. LPs aren’t necessarily comfortable with the development, but there’s only so much they can do about it
China VCs back See Fund's debut vehicle
See Fund, an investment firm established by the founder of Chinese artificial intelligence chip start-up DeePhi Technology, has raised RMB200 million ($31 million) for its debut fund.
VCs commit $50m to China's Medilink Therapeutics
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed raises $800m for Asia life sciences fund
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.
China cloud IoT provider Tuya files for US IPO
Tuya, a Chinese software platform for internet-of-things (IoT) systems that mainly offers platform-as-a-service (PaaS) products is pursuing a US IPO.
ESG & operations: Compliance corner
Few mid-market private equity firms in Asia have dedicated ESG personnel and this is not necessarily an obstacle to progress. As compliance and reporting burdens increase, the status quo may change
Lunar buys majority stake in Hong Kong IVF business
Chinese middle-market buyout firm Lunar has agreed to acquire a women’s health and IVF business from Mason Group, a Hong Kong conglomerate with interests in financial services and healthcare, for HK$268 million ($34.5 million).
Hillhouse launches China sports retail JV with US-based Fanatics
Hillhouse Capital has established a China joint venture with Fanatics, a US-based sports retailer that specializes in licensed sports apparel.
China EV battery maker raises $542m Series A
Svolt Energy Technology, formerly the battery business unit of Chinese automaker Great Wall Motor, has raised a RMB3.5 billion ($542 million) Series A round featuring a string of government-linked investors.